Event Title

The Effects of Increased Telemedicine Appointments due to COVID-19 on the Amount of Cancer Screenings Ordered/Performed

Presenter Information

Rana Hanna
Helena Beltran

Loading...

Media is loading
 

Comments

Poster Presentation

Please select your campus affiliation

Tampa

Mentor Information

Karim Hanna

Description

At the start of the COVID-19 pandemic, cancer screenings began to be delayed as in-person clinical visits were restricted. As a response to the pandemic, the use of telemedicine rapidly increased as a new technological platform used for remote patient care. Telehealth has become an essential means of communication between clinicians and their patients. Despite these advancements, limitations were still present amongst patients needing screenings. Although there is little consensus on the effectiveness of telehealth services in patients requiring oncological screenings during the pandemic due to its recency and the progressive nature of cancer, this research will serve the purpose of comparing the efficacy of telehealth-based services during the COVID-19 pandemic versus in-person clinic before COVID-19. With the necessity of routine cancer screenings for early detection and treatment, our research aims to evaluate the extent to which the increased use of telemedicine has affected procedural screenings during the COVID-19 pandemic. Ultimately, we hypothesize that the increased use of telemedicine during the COVID-19 pandemic led to a decreased amount of cancer screenings ordered/performed in patients.

This document is currently not available here.

Share

COinS
 

The Effects of Increased Telemedicine Appointments due to COVID-19 on the Amount of Cancer Screenings Ordered/Performed

At the start of the COVID-19 pandemic, cancer screenings began to be delayed as in-person clinical visits were restricted. As a response to the pandemic, the use of telemedicine rapidly increased as a new technological platform used for remote patient care. Telehealth has become an essential means of communication between clinicians and their patients. Despite these advancements, limitations were still present amongst patients needing screenings. Although there is little consensus on the effectiveness of telehealth services in patients requiring oncological screenings during the pandemic due to its recency and the progressive nature of cancer, this research will serve the purpose of comparing the efficacy of telehealth-based services during the COVID-19 pandemic versus in-person clinic before COVID-19. With the necessity of routine cancer screenings for early detection and treatment, our research aims to evaluate the extent to which the increased use of telemedicine has affected procedural screenings during the COVID-19 pandemic. Ultimately, we hypothesize that the increased use of telemedicine during the COVID-19 pandemic led to a decreased amount of cancer screenings ordered/performed in patients.